OSTEOPOROSIS POSTMENOPAUSAL
Clinical trials for OSTEOPOROSIS POSTMENOPAUSAL explained in plain language.
Never miss a new study
Get alerted when new OSTEOPOROSIS POSTMENOPAUSAL trials appear
Sign up with your email to follow new studies for OSTEOPOROSIS POSTMENOPAUSAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could adding a second drug boost bone strength in osteoporosis?
Disease control OngoingThis study looks at whether adding the drug abaloparatide (Tymlos) to the standard treatment denosumab (Prolia) can improve bone density more than denosumab alone in postmenopausal women with osteoporosis. Seventy women who have already been on denosumab will either continue with…
Matched conditions: OSTEOPOROSIS POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug combo aims to strengthen bones in elderly women
Disease control OngoingThis study tests whether a year of monthly injections of romosozumab, followed by an infusion of zoledronic acid, can improve bone density and prevent fractures in women aged 65 and older with osteoporosis who live in long-term care facilities. The goal is to find a treatment tha…
Matched conditions: OSTEOPOROSIS POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Susan L. Greenspan • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New study tests drug combo to keep bones strong after osteoporosis treatment ends
Disease control OngoingThis study looks at whether giving zoledronate infusions can prevent bone loss in postmenopausal women who have stopped taking denosumab for osteoporosis. About 200 women who took denosumab for at least two years will receive zoledronate at different times. The goal is to find th…
Matched conditions: OSTEOPOROSIS POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Osteoporosis exercise-drug combo study pulled before starting
Knowledge-focused TerminatedThis study was designed to test whether adding arm exercises to a standard osteoporosis medication could improve bone density in the wrist. It was planned for postmenopausal women at high fracture risk. However, the study was withdrawn before enrolling any participants, so no res…
Matched conditions: OSTEOPOROSIS POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC